republic-os/legislation/us/states/nj/219/a-277.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.*	Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.*	us/states/nj	New Jersey Legislature	219	A 277	New Jersey A 277 (219)	bill	PHARMACEUTIC	enacted	Armato, John Karabinchak, Robert J. Singleton, Troy Turner, Shirley K.	2	8	4	2020-01-14T05:00:00+00:00	2021-11-08T05:00:00+00:00	openstates	ocd-bill/3b9d5b25-87bf-48fe-9f19-1b3cff408b4d	http://www.njleg.state.nj.us/downloads.asp	94fb727d9a8470626c75dde65f545aaf5060a97ba469de928bdbde4b9d5d56d7	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-nj

New Jersey A 277 (219) — Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.*

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Introduced Version (committee substitute) — source
2. Reprint (committee substitute) — source

Votes

• 3RDG FINAL PASSAGE — 74–0 (pass) · lower
• 3RDG FINAL PASSAGE — 38–0 (pass) · upper
• Reported out of Assembly committee with amendments — 12–0 (pass) · lower
• Reported favorably out of committee — 8–0 (pass) · upper

Sponsors

• Armato, John — primary (person)
• Karabinchak, Robert J. — primary (person)
• Singleton, Troy — primary (person)
• Turner, Shirley K. — primary (person)
• Downey, Joann — cosponsor (person)
• Freiman, Roy — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2020-01-14T05:00:00+00:00 Introduced in the Assembly, Referred to Assembly Health Committee introduction, referral-committee
• 2020-03-05T05:00:00+00:00 Reported out of Assembly Committee with Amendments, 2nd Reading committee-passage
• 2020-07-30T04:00:00+00:00 Passed Assembly (74-0-0) passage
• 2020-08-03T04:00:00+00:00 Received in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee referral-committee
• 2021-02-09T05:00:00+00:00 Reported out of Senate Committee, 2nd Reading committee-passage
• 2021-06-03T04:00:00+00:00 Substituted for S2035 (1R)
• 2021-06-03T04:00:00+00:00 Passed Senate (Passed Both Houses) (38-0) passage
• 2021-11-08T05:00:00+00:00 Approved P.L.2021, c.285. executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/3b9d5b25-87bf-48fe-9f19-1b3cff408b4d. Confidence: reported (aggregated from official New Jersey legislature records).